• Praluent® can be injected subcutaneously into the thigh, abdomen or upper arm. Patients should rotate the injection site with each injection.1

    For the 300 mg dose, patients should administer two consecutive 150 mg injections at different injection sites.1

    Watch the video below to see how your patients should inject themselves using the Praluent® prefilled pen.

     

    For more information on administration, see the method of administration section of the Prescribing Information or our instruction guides:

    Resources

    • NAME
      SIZE
       
    • Praluent® Prefilled Pen 75 mg Instructions for Use
      5.6mb
       
    • Praluent® Prefilled Pen 150 mg Instructions for Use
      5.6mb
       

    PRALUENT DOSING

    Learn more

    PRALUENT ADMINISTRATION

    Learn more
    1. Praluent® (alirocumab) European Summary of Product Characteristics. March 2019.